BenevolentAI
Drug Discovery · Drug Discovery AI

BenevolentAI: Funding & valuation

BenevolentAI: 7 money records, each linked to its source.

Financials

Funding rounds, investors and revenue on record.

Venture - Series UnknownLatest round
7Rounds and grants3 investors
Money by yearUSD, rounds and grants
2022-1 record
2021-1 record
2019-3 records
2018-1 record
2016-1 record
Investors
AstraZeneca
AstraZeneca partnered with BenevolentAI on target identification in chronic kidney disease and pulmonary fibrosis. The collaboration produced several jointly validated targets.
Woodford Investment Management
Woodford Investment Management was an early and large backer of BenevolentAI. The fund's later collapse forced a restructuring of the shareholder base.
Temasek
Temasek led BenevolentAI's 2019 financing round. The Singapore state investor holds a broad life sciences portfolio.
Sources: funding announcements, grant and company registers

Money

BenevolentAI: 7 money records, each linked to its source.

StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Apr 2022 · Venture round
not statedPaid
Equity raised
Feb 2021 · Venture round
not statedPaid
Equity raised
Dec 2019 · Venture round
not statedPaid
4 more records: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".